📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-14 19:32
570 analysed today
570
Today
133,459
All-time analysed
40,112
Positive
6,281
Negative
79,251
Neutral
7,747
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
12 announcements match the current filters (relevance ≥ 5).
Primo Chemicals Approves In-Principle Scheme to Merge Flow Tech Post 51% Stake Buyout
Primo Chemicals' Board has granted in-principle approval to formulate a Scheme of Amalgamation to merge Flow Tech Chemicals Private Limited into Primo. This follows shareholder approval obtained on August 5, 2026, to acquire the balance 51% equity stake in Flow Tech to make it a wholly owned subsidiary. The merger aims to simplify group corporate structure, reduce compliance overheads, and give direct operational control over Flow Tech's assets. The restructuring is subject to completing the 51% buyout, formal board approval of the scheme, and regulatory clearances including NCLT and SEBI.
Confidence: HIGH
What changedThe Board initiated the formal process to absorb Flow Tech Chemicals into Primo once it becomes a 100% wholly owned subsidiary.
Why it mattersAmalgamation removes intermediate holding structures, reduces administrative and compliance costs, and provides unified operational control over combined chemical assets.
Flow Tech stake under acquisition: 51%Shareholder approval date for 51% buyout: August 5, 202651st AGM date: September 30, 2026Book closure period: September 24, 2026 to September 30, 2026
📅 Short termNear-term focus remains on the operational closure of the 51% stake purchase and engagement of intermediaries to draft the merger scheme.
📈 Long termStructural consolidation will streamline Primo's corporate footprint, reduce compliance drag, and integrate chemical manufacturing resources directly.
⚠ Risk flags
- Execution and closing conditions for the balance 51% stake acquisition
- Multi-step regulatory approvals required including NCLT, SEBI, and stock exchanges
Key Highlights
In-principle approval granted for the amalgamation of Flow Tech Chemicals into Primo Chemicals.
Primo is finalizing the acquisition of the remaining 51% stake in Flow Tech, approved by shareholders on August 5, 2026.
The 51st Annual General Meeting is scheduled for September 30, 2026, via video conferencing.
Share transfer books and register of members will be closed from September 24 to September 30, 2026.
M/s Kabra & Associates re-appointed as Cost Auditor for FY 2026-27.
👀 What to Watch
Monitor the formal completion of the 51% stake acquisition under the Supplementary SPA and the subsequent Board approval of the final Scheme of Amalgamation with valuation details.
Rs 4.03 Cr Q1 Net Profit; Revenue Drops 71% YoY; Flow Tech Acquisition Progresses
Primo Chemicals reported a significant 71.6% YoY decline in standalone revenue to Rs 40.28 Cr for Q1 FY27. Despite the top-line contraction, net profit grew 31.7% YoY to Rs 4.03 Cr, aided by a sharp reduction in total expenses from Rs 138.89 Cr to Rs 33.46 Cr. The company is also moving forward with the acquisition of the remaining 51% stake in its associate, Flow Tech Chemicals, following shareholder approval on August 5, 2026.
Confidence: HIGH
What changedThe company reported its Q1 FY27 results showing a massive revenue decline but improved profitability, and confirmed the ongoing process to make Flow Tech Chemicals a wholly-owned subsidiary.
Why it mattersThe sharp revenue drop suggests a potential change in business mix or severe industry headwinds, while the acquisition of Flow Tech Chemicals represents a strategic move to consolidate operations and potentially improve margins through downstream integration.
Revenue (Q1 FY27): Rs 40.28 CrNet Profit (Q1 FY27): Rs 4.03 CrRevenue Growth (YoY): -71.6%Net Profit Growth (YoY): +31.7%Q1 Revenue vs TTM Revenue: ~14.3%
📅 Short termThe market may react with caution to the drastic revenue decline, although the growth in net profit and the M&A progress provide a positive counter-narrative.
📈 Long termThe structural shift towards downstream products like Paracetamol and Hydrogen Peroxide, combined with the full acquisition of Flow Tech, will be the key determinants of long-term value.
⚠ Risk flags
- Extreme revenue volatility (71% YoY decline)
- High P/E ratio of 144.7 relative to small profit base
- Cyclical risks inherent in the chlor-alkali industry
Key Highlights
Standalone revenue fell sharply to Rs 40.28 Cr from Rs 141.94 Cr in the year-ago quarter.
Net profit increased to Rs 4.03 Cr, up from Rs 3.06 Cr in Q1 FY26.
Total expenses decreased by 75.9% YoY to Rs 33.46 Cr, significantly impacting margins.
Shareholders approved the transition of Flow Tech Chemicals from a 49% associate to a 100% subsidiary on August 5, 2026.
Earnings per share (EPS) for the quarter stood at Rs 0.17, compared to Rs 0.13 in the previous year's corresponding quarter.
👀 What to Watch
Investors should monitor the reasons behind the 71% revenue drop and the timeline for the full integration of Flow Tech Chemicals, which could alter the consolidated financial profile.
Primo Chemicals Shareholders Approve 51% Stake Acquisition in Flow Tech Chemicals
Shareholders of Primo Chemicals have approved the acquisition of the remaining 51% stake in Flow Tech Chemicals Private Limited, which will now become a wholly-owned subsidiary. The resolution was passed with 99.98% of valid votes in favor (8,26,54,322 votes). Additionally, the board secured approval for the appointment of two Independent Directors and the remuneration for the Managing Director and Executive Director for their remaining two-year terms. This consolidation aligns with the company's stated strategy of downstream integration to improve margins.
Confidence: HIGH
What changedPrimo Chemicals has received shareholder mandate to move from a partial stake to 100% ownership of Flow Tech Chemicals Private Limited.
Why it mattersMaking Flow Tech a wholly-owned subsidiary facilitates better operational integration and financial consolidation, supporting the company's goal to increase internal chlorine consumption and reduce dependence on cyclical caustic soda sales.
Stake to be acquired: 51%Votes in favor of acquisition: 99.98%Total shareholders on record date: 49,055Record date: 2026-07-03Acquisition value: not disclosed
📅 Short termThe successful passing of all resolutions, particularly the acquisition and management remuneration, provides administrative clarity and may be viewed positively by the market in the coming weeks.
📈 Long termFull ownership of Flow Tech Chemicals is a structural step toward the company's downstream integration strategy, potentially stabilizing margins against commodity chemical cycles over the next 2-3 years.
⚠ Risk flags
- Integration risk of the new wholly-owned subsidiary
- Cyclical nature of the core caustic soda business
Key Highlights
Approval to acquire the balance 51% stake in Flow Tech Chemicals Private Limited with 99.98% majority.
Appointment of Shri Dibakar Sarkar and Shri Sobhag Mal Jain as Independent Directors approved via special resolutions.
Remuneration for MD Naveen Chopra and ED Jatin Dahiya approved for the remaining 2 years of their current terms.
Total of 49,055 shareholders were on record as of the July 3, 2026, record date for the postal ballot.
The acquisition resolution received 8,26,54,322 votes in favor versus only 15,570 votes against.
👀 What to Watch
Investors should monitor the financial consolidation of Flow Tech Chemicals in upcoming quarterly reports and track the progress of the company's downstream integration into Paracetamol API and Hydrogen Peroxide.
Primo Chemicals to Acquire 51% Stake in Flow Tech; Target FY26 Revenue at Rs 341.66 Cr
Primo Chemicals has approved the acquisition of the remaining 51% stake in Flow Tech Chemicals, moving from 49% to 100% ownership. The target company is significantly larger than the parent in terms of revenue, reporting FY26 turnover of Rs 341.66 Cr compared to Primo's TTM revenue of Rs 282 Cr. The acquisition is priced at Rs 1,418.20 per share, which is an 8.2% discount to the fair value of Rs 1,545.40 determined by BDO. This strategic move secures a captive outlet for Primo's byproduct chlorine, essential for maintaining high caustic soda production levels.
Confidence: HIGH
What changedPrimo Chemicals is transitioning Flow Tech Chemicals from an associate company (49% stake) to a 100% wholly owned subsidiary.
Why it mattersThe acquisition provides a guaranteed downstream outlet for chlorine, a byproduct that often limits caustic soda production. Consolidating a high-growth, profitable entity (FY26 PAT of Rs 9.80 Cr) will materially improve Primo's consolidated financial profile.
Target FY26 Turnover: Rs 341.66 CrTarget vs Parent TTM Revenue: ~121%Acquisition Price per Share: Rs 1,418.20Fair Value per Share: Rs 1,545.40Target FY26 PAT: Rs 9.80 Cr
📅 Short termPositive market reaction expected due to the scale of the acquisition and the favorable valuation (discount to fair value).
📈 Long termStructurally positive as it integrates the value chain, reduces chlorine disposal risks, and adds a high-growth revenue stream to the consolidated entity.
⚠ Risk flags
🔬 Flagged for deeper Multibagger analysis — view briefs →
- Related-party transaction (target is part of promoter group)
- Cyclicality of the chemical industry impacting both parent and target
- Requirement of shareholder approval via special resolution
Key Highlights
Acquisition of 51% stake (3,88,930 shares) to make Flow Tech a 100% wholly owned subsidiary
Target FY26 turnover of Rs 341.66 Cr represents ~121% of Primo Chemicals' TTM revenue
Acquisition price of Rs 1,418.20 per share is below the fair valuation of Rs 1,545.40
Flow Tech PAT grew nearly 10x in two years, from Rs 1.02 Cr in FY24 to Rs 9.80 Cr in FY26
The transaction is expected to be completed by March 31, 2027, subject to shareholder approval
👀 What to Watch
Monitor the results of the Postal Ballot ending August 5, 2026, and watch for the subsequent consolidation of Flow Tech's financials which will significantly scale the company's top and bottom lines.
Primo Chemicals Assigned CRISIL BBB/Stable Rating for Rs 180 Crore Bank Facilities
CRISIL Ratings has assigned new credit ratings to Primo Chemicals Limited for its bank loan facilities totaling Rs 180 Crore. The company received a long-term rating of 'CRISIL BBB' with a 'Stable' outlook and a short-term rating of 'CRISIL A3+'. This formal credit assessment provides transparency regarding the company's debt-servicing capabilities and financial stability. The assignment of an investment-grade rating is a positive step for the company's future capital raising and borrowing costs.
Key Highlights
CRISIL assigned a Long Term Rating of CRISIL BBB with a Stable outlook.
Short Term Rating assigned at CRISIL A3+ for the company's facilities.
Total bank loan facilities covered under this rating amount to Rs 180 Crore.
The rating assignment was communicated via CRISIL on June 26, 2026.
👀 What to Watch
Investors should monitor the company's ability to maintain or improve this investment-grade rating, as it directly impacts their cost of debt. The stable outlook indicates a steady financial trajectory in the medium term.
Primo Chemicals to Invest ₹21 Crore for 26% Stake in 49.998 MW Solar Power Project
Primo Chemicals Limited has formally executed agreements to acquire a 26% equity stake in TPCS Private Limited for ₹21 crores. This Special Purpose Vehicle (SPV) is set to develop and operate a 49.998 MW AC Solar Power Plant under a captive OPEX model. The arrangement ensures a dedicated renewable energy source for the company, potentially lowering and stabilizing long-term power costs. The agreement grants Primo significant rights, including veto powers over major corporate changes and a right of first refusal on future stake transfers.
Key Highlights
Investment of ₹21 crores for a 26% equity stake in SPV TPCS Private Limited
Project involves a 49.998 MW AC Solar Power Plant under captive mode
Execution of Power Purchase Agreement (PPA) and Share Subscription Agreement (SSSHA)
Primo retains veto rights on capital structure changes and right of first refusal
👀 What to Watch
Investors should view this as a strategic move to reduce energy costs and improve ESG ratings. Track the project's completion timeline to assess when the operational savings will reflect in the bottom line.
Primo Chemicals to Invest ₹21 Cr in 50 MW Solar SPV; Expects ₹24 Cr Annual Cost Savings
Primo Chemicals has approved a ₹21 crore investment to acquire a 26% equity stake in TPCS Private Limited, an SPV formed to set up a 50 MW solar power plant. The project will operate under a captive mode on an OPEX model, specifically designed to power the company's operations. This strategic move is expected to generate significant operational efficiencies, with projected annual cost savings of approximately ₹24 crores. The SPV is already incorporated, and the company is currently finalizing the Power Purchase and Share Subscription Agreements.
Key Highlights
Investment of ₹21 crores for a 26% equity stake in the SPV, TPCS Private Limited
Development of a 50 MW Solar Power Plant under captive mode on an OPEX model
Anticipated annual cost savings of up to ₹24 crores upon project commissioning
SPV incorporated on February 13, 2026, with PPA and Share Subscription Agreements in progress
👀 What to Watch
Investors should monitor the execution timeline of the PPA and commissioning dates, as the projected ₹24 crore annual savings represent a significant boost to the company's bottom line relative to the ₹21 crore investment.
Primo Chemicals to Acquire Remaining 51% Stake in Flow Tech; Announces Management Changes
Primo Chemicals has approved the acquisition of the remaining 51% stake in Flow Tech Chemicals Private Limited, a promoter group company, to be completed by March 31, 2027. Flow Tech is a profitable entity with FY26 turnover of ₹341.66 crore and PAT of ₹9.80 crore, showing significant growth from ₹1.02 crore PAT in FY24. The board also appointed two new Independent Directors, Mr. Dibakar Sarkar and Mr. Sobhag Mal Jain, for five-year terms. Additionally, the Senior VP of Operations, Mr. Munish Aggarwal, has resigned effective May 10, 2026.
Key Highlights
Acquisition of 51% stake in Flow Tech Chemicals to achieve 100% ownership by March 2027.
Flow Tech's revenue grew from ₹227.96 crore in FY24 to ₹341.66 crore in FY26.
Flow Tech's PAT surged nearly 10x over two years, reaching ₹9.80 crore in FY26.
Appointment of two Independent Directors with backgrounds in government service and LIC finance.
Resignation of Senior VP (Operations) Munish Aggarwal effective May 10, 2026.
👀 What to Watch
Investors should monitor the final valuation of the Flow Tech acquisition as it is a related-party transaction. The vertical integration is expected to improve chlorine disposal efficiency and overall margins.
Primo Chemicals FY26 PAT Surges 349% to ₹10.56 Cr; Significant Debt Reduction
Primo Chemicals reported a strong financial performance for FY26, with net profit jumping to ₹10.56 crore from ₹2.35 crore in the previous year. While annual revenue remained relatively flat at ₹561.69 crore, the company achieved a significant turnaround in Q4, posting a profit of ₹5.09 crore against a loss in the previous year's quarter. A key highlight is the reduction in long-term debt by over ₹23 crore, improving the overall financial health. The company also managed to maintain robust operating cash flows of ₹64.68 crore.
Key Highlights
FY26 Net Profit increased by 349% YoY to ₹1,056.29 lakhs from ₹235.21 lakhs.
Long-term borrowings significantly reduced from ₹7,997.83 lakhs to ₹5,694.78 lakhs.
Q4 FY26 PAT turned positive at ₹509.39 lakhs vs a loss of ₹111.95 lakhs in Q4 FY25.
Annual EPS rose significantly to ₹0.44 from ₹0.10 in the previous fiscal.
Net cash from operating activities stood strong at ₹6,468.33 lakhs for the full year.
👀 What to Watch
The company shows strong fundamental improvement through debt deleveraging and profit margin expansion. Investors should monitor if the company can trigger top-line growth to sustain this earnings momentum.
Primo Chemicals Appoints Anoop Kumar Kabra as CFO; Sunil Parsad Transitions to New Role
Primo Chemicals Limited has appointed Shri Anoop Kumar Kabra as Chief Financial Officer (CFO) effective February 27, 2026. Mr. Kabra is a Chartered Accountant and Cost Accountant with over 25 years of experience in financial management and corporate restructuring. The outgoing CFO, CA Sunil Parsad, will continue to serve the organization in a non-Key Managerial Personnel role. This transition suggests a planned internal realignment of leadership responsibilities rather than an abrupt departure.
Key Highlights
Shri Anoop Kumar Kabra to take over as CFO and KMP from February 27, 2026
Incoming CFO brings 25+ years of expertise in accounting, MIS, and risk mitigation
Current CFO Sunil Parsad will transition to a new internal role, ensuring organizational continuity
Board approval for the change was granted on February 12, 2026, following committee recommendations
👀 What to Watch
Monitor the company's financial disclosures post-February 2026 for any shifts in accounting practices or financial strategy under the new leadership.
Primo Chemicals Q3 Consolidated Net Profit Declines 54% YoY to ₹1.05 Crore
Primo Chemicals reported a consolidated net profit of ₹105.47 lakhs for Q3 FY26, marking a 54% decline from ₹229.46 lakhs in the same quarter last year. Revenue from operations remained nearly flat at ₹140.14 crore compared to ₹143.85 crore YoY. The profitability was significantly impacted by a 25% YoY surge in power costs, which rose to ₹54.33 crore. Despite the quarterly setback, the nine-month net profit for FY26 shows a strong recovery at ₹9.30 crore, up 134% from ₹3.97 crore in the previous year.
Key Highlights
Consolidated Net Profit fell 54% YoY to ₹105.47 lakhs in Q3 FY26 from ₹229.46 lakhs.
Power expenses surged by 25.2% YoY to ₹5,433.51 lakhs, significantly impacting margins.
Revenue from operations saw a marginal decline of 2.6% YoY to ₹14,014.01 lakhs.
Nine-month (9M FY26) Net Profit stands at ₹929.61 lakhs, a 134% increase over 9M FY25.
Recognized an exceptional item of ₹20.06 lakhs as provision for the new statutory Labour Codes.
👀 What to Watch
Investors should be cautious of the sharp margin compression caused by rising power costs, which is a critical input for chemical manufacturing. While the 9-month growth trend is positive, the volatility in quarterly earnings suggests waiting for stabilization in energy costs before increasing exposure.
Primo Chemicals to Invest Rs 21 Cr in 50 MW Solar Project; Expects Rs 24 Cr Annual Savings
Primo Chemicals has approved a strategic investment of Rs 21 crores to acquire a 26% equity stake in a Special Purpose Vehicle (SPV) for a 50 MW Solar Power Plant. The project will operate under a captive mode on an OPEX model, providing the company with power at a fixed tariff. This initiative is highly significant as it is projected to result in annual cost savings of up to Rs 24 crores once commissioned. The move is part of the company's strategy to reduce operational costs and shift toward renewable energy sources in Punjab.
Key Highlights
Investment of Rs 21 crores for a 26% equity stake in a new Solar SPV.
Development of a 50 MW Solar Power Plant under captive mode and OPEX model.
Anticipated annual cost savings of up to Rs 24 crores, exceeding the initial investment amount.
Partnership with Sun Photonics Private Limited for renewable energy generation and transmission.
Project aligns with Punjab's open access and captive power policy under prevailing electricity laws.
👀 What to Watch
This is a highly value-accretive move with a potential payback period of less than one year based on projected savings. Investors should view this as a significant margin-expansion catalyst and monitor the project's commissioning timeline.
